Dabrafenib Mesylate
Dabrafenib Mesylate is a B-Raf inhibitor (IC50s of 0.6 and 5.0 nM for RafV600E and c-Raf, respectively) .In human endothelial cells, Dabrafenib inhibits the release of HMGB1 and down-regulates the HMGB1-dependent inflammatory response by enhancing the expression of cell adhesion molecules (CAM) .
Product Specifications
CAS Number
1195768-06-9
Product Name Alternative
GSK2118436 Mesylate, GSK 2118436B
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO:34 mg/mL (55.22 mM)
Smiles
CS (O) (=O) =O.CC (C) (C) C1=NC (=C (S1) C1=NC (N) =NC=C1) C1=C (F) C (NS (=O) (=O) C2=C (F) C=CC=C2F) =CC=C1
Molecular Formula
C24H24F3N5O5S3
Molecular Weight
615.67
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1964-100 1x 100 µL
NGF-Receptor (p75) / CD271 (Soft Tissue Tumor Marker) (NGFR/1964), 0.2mg/mL
Sign In for Pricing
View Details 
TRC-P998580-1MG 1 mg
(2Beta,3Alpha,5Alpha,16Beta,17Beta)-2,16-di-1-Pyrrolidinylandrostane-3,17-diol
Sign In for Pricing
View Details 
BNC401692-100 1x 100 µL
Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (LL025), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 